All Dr. Christopher Duma (Founder – Regeneration Biomedical and Medical Director of the Brain Tumor Program - Hoag Memorial Presbyterian Hospital) articles

  • 3d,Illustration,Of,Nerve,Cells,,Concept,For,Neurological,Diseases,,Tumors
    Article

    Inside the Alzheimer’s study backing stem cells, not drugs

    2025-08-26T09:00:27Z

    In this first-in-human Alzheimer’s study, Wnt-activated autologous stem cells are delivered intracerebroventricularly (directly into the brain) to address neuronal loss, while also reducing amyloid and tau biomarkers and improving cognition. Early data from this regenerative approach could help early drug discovery teams shape target selection, biomarker development and trial design.